| CAS No | Product Name | Molecular Formula |
|---|---|---|
| 1604818-10-1 | tert-Butyl 6-chloro-3,3-dimethyl-2,3-dihydro-1H-pyrrolo[3,2-b]pyridine-1-carboxylate | C14H19ClN2O2 |
| 1605304-56-0 | 2-(3,4-Dihydroxyphenyl)-8-[(2E)-3,7-dimethyl-2,6-octadien-1-yl]-5,7-dihydroxy-3-methoxy-4H-1-benzopyran-4-one | C26H28O7 |
| 1605314-84-8 | Cefprozil Monohydrate EP Impurity M | C21H23N3O7S |
| 1605314-85-9 | Cefprozil Monohydrate EP Impurity N | C21H23N3O7S |
| 1606981-69-4 | 2-(3'-Bromo[1,1'-biphenyl]-3-yl)-4,6-diphenyl-1,3,5-triazine | C27H18BrN3 |
| 1607799-13-2 | Bremelanotide acetate | C50H68N14O10.C2H4O2 |
| 1607837-31-9 | 8-[2-Amino-3-chloro-5-(1-methyl-1H-indazol-5-yl)-4-pyridinyl]-2,8-diazaspiro[4.5]decan-1-one | C21H23ClN6O |
| 1608125-21-8 | (alphaS)-7-Fluoro-alpha-methyl-N-9H-purin-6-yl-2-(2-pyridinyl)-3-quinolinemethanamine | C21H16FN7 |
| 1608127-32-7 | Val-Cit-PAB-MMAE | C58H94N10O12 .C2HF3O2 |
| 1608459-56-8 | Prucalopride Impurity 20 | C18H27N3O3 |
| 1608495-96-0 | Folate-amido-C2-amine-endo-BCN | C32H37N9O7 |
| 1609073-29-1 | 2-Amino-4,5-bis[(4-methoxyphenyl)methoxy]benzoic acid | C23H23NO6 |
| 1609119-58-5 | 5-(1E )-1-Propen-1-yl-1H -Pyrazol-3-amine | C6H9N3 |
| 1609259-26-8 | 4-Chloro-1H-pyrrolo[3,2-c]pyridine-1-carboxylic acid 1,1-dimethylethyl ester | C12H13ClN2O2 |
| 1609267-04-0 | 9-[1,1'-Biphenyl]-2-yl-3-bromo-9H-carbazole | C24H16BrN |
| 1609267-35-7 | [9-(3-Methylphenyl)-9H-carbazol-3-yl]boronic acid | C19H16BNO2 |
| 1609267-58-4 | 3-Bromo-N-(2-biphenylyl)carbazole | C24H16BrN |
| 1609281-86-8 | 2-[(Aminocarbonyl)amino]-5-[4-(3,5-dimethyl-4-isoxazolyl)-2-[(3S)-3-pyrrolidinyloxy]phenyl]-3-thiophenecarboxamide | C21H23N5O4S |
| 1609373-91-2 | Benzofuro[2,3-b]pyridin-8-ol | C11H7NO2 |
| 1609373-98-9 | 1,1,1-Trifluoromethanesulfonic acid 2-methylbenzofuro[2,3-b]pyridin-8-yl ester | C13H8F3NO4S |
| 1609373-99-0 | 2-Methyl-8-(2-pyridinyl)benzofuro[2,3-b]pyridine | C17H12N2O |
| 1609392-27-9 | Deucravacitinib | C20D3H19N8O3 |
| 1609394-10-6 | 2-Methoxy-3-(1-methyl-1H-1,2,4-triazol-3-yl)aniline | C10H12N4O |
| 1609402-14-3 | N-[4-[3-[[[5-(Dimethylamino)-1-naphthalenyl]sulfonyl]amino]phenyl]-2-thiazolyl]acetamide | C23H22N4O3S2 |
| 1609402-46-1 | N-(5-Chloro-3-hydroxy-2-pyridinyl)carbamic acid 1,1-dimethylethyl ester | C10H13ClN2O3 |
| 1609484-28-7 | 3-Bromospiro[9H-fluorene-9,9'-[9H]xanthene] | C25H15BrO |
| 1609484-31-2 | 9,9-Dimethyl-N-[1,1':3',1''-terphenyl]-4'-yl-9H-fluoren-2-amine | C33H27N |
| 1609484-45-8 | 4-Bromospiro[9H-fluorene-9,9'-[9H]xanthene] | C25H15BrO |
| 1609484-77-6 | N-([1,1'-Biphenyl]-3-yl)-[1,1':3',1''-terphenyl]-4'-amine | C30H23N |
| 1609584-72-6 | 1-[3-Methoxy-4-[[6-[[2-[(1-methylethyl)sulfonyl]phenyl]amino]-9H-purin-2-yl]amino]phenyl]-4-piperidinol | C26H31N7O4S |
| 1609652-39-2 | trans-5-Butyl-2-[4-[[3,5-difluoro-4-[(1,1,2,3,3-pentafluoro-2-propen-1-yl)oxy]phenoxy]difluoromethyl]-3,5-difluorophenyl]-1,3-dioxane | C24H19F11O4 |
| 1609652-65-4 | trans-5-Butyl-2-[4'-[[3,5-difluoro-4-[(1,1,2,3,3-pentafluoro-2-propen-1-yl)oxy]phenoxy]difluoromethyl]-3',5'-difluoro[1,1'-biphenyl]-4-yl]-1,3-dioxane | C30H23F11O4 |
| 1609653-18-0 | 4-[[2,6-Difluoro-4-(trans-5-propyl-1,3-dioxan-2-yl)phenyl]difluoromethoxy]-2,6-difluorophenol | C20H18F6O4 |
| 1609960-30-6 | 6-(2,3-Dichlorophenyl)-N4-methyl-2,4-pyrimidinediamine | C11H10Cl2N4 |
| 1609960-31-7 | N4-Cyclopropyl-6-(2,3-dichlorophenyl)-2,4-pyrimidinediamine | C13H12Cl2N4 |
| 1610043-62-3 | 5-(2-Fluorophenyl)-N-methyl-1H-pyrrole-3-methanamine | C12H13FN2 |
| 1610413-97-2 | 12-(4-((9S,13S)-9,13-Bis(tert-butoxycarbonyl)-18,18-dimethyl-3,11,16-trioxo-17-oxa-2,4,10,12-tetraazanonadecyl)phenyl)acetic acid | C34H54N4O10 |
| 1610527-49-5 | 2,4-Dimethyl-1-[(2-nitrophenyl)thio]benzene | C14H13NO2S |
| 1610537-15-9 | Seviteronel | C18H17F4N3O3 |
| 1610586-62-3 | 2-Methoxy-4-(1H-pyrazol-4-yl)-N-(2,3,4,5-tetrahydro-1H-3-benzazepin-7-yl)benzamide | C21H22N4O2 |
| 1610758-19-4 | N-[[2-[[[4-[[[(Hexyloxy)carbonyl]amino]iminomethyl]phenyl]amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]-N-2-pyridinyl-beta-alanine 1-methylethyl ester | C35H43N7O5 |
| 1610758-20-7 | N-[[2-[[[4-[[[(2-Ethylbutoxy)carbonyl]amino]iminomethyl]phenyl]amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]-N-2-pyridinyl-beta-alanine ethyl ester | C34H41N7O5 |
| 1610758-21-8 | N-[[2-[[[4-[Imino[[[(1-methylhexyl)oxy]carbonyl]amino]methyl]phenyl]amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]-N-2-pyridinyl-beta-alanine ethyl ester | C35H43N7O5 |
| 1610758-22-9 | N-[[2-[[[4-[[[(1-Ethylbutoxy)carbonyl]amino]iminomethyl]phenyl]amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]-N-2-pyridinyl-beta-alanine ethyl ester | C34H41N7O5 |
| 1610878-71-1 | 1-[(3S,8S,9S,10R,13S,14S,17S)-3-[(4-methoxyphenyl)methoxy]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]ethanone | C29H40O3 |
| 1610882-30-8 | (2S)-1-(3,4-Dihydro-6,7-dimethoxy-2(1H)-isoquinolinyl)-3,3-dimethyl-2-[(4-pyridinylmethyl)amino]-1-butanone hydrochloride (1:1) | C23H31N3O3.HCl |
| 1611469-80-7 | 1-(3-Bromopropyl)-4-octylbenzene | C17H27Br |
| 1611490-64-2 | UDP-GlcNAz.2Na | C17H24N6O17P2Na2 |
| 1611493-60-7 | Bictegravir | C21H18F3N3O5 |
| 1612153-32-8 | (4R)-3-[(5R)-5-(4-Fluorophenyl)-5-hydroxy-1-oxopentyl]-4-phenyl-2-oxazolidinone | C20H20FNO4 |